Abstract
In June 2020, a 54-year-old female presented with severe fatigue that had been worsening over the past few weeks. She had a history of primary triple positive (lupus anticoagulant, anticardiolipin and anti-β2GP1 antibodies) antiphospholipid syndrome (APS) revealed 19 years ago by a venous thromboembolism, and had been long-term treated with warfarin.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
